Abstract: The present document related to the processing of mining materials, such as ores, rocks, minerals, and aggregate materials to separate valuable components. There is provided a process and system for extracting a valuable component from a mining feedstock comprising geological materials. The process can comprise subjecting the mining feedstock to a kinetic pulverization stage wherein the mining feedstock is subjected to self-collisions created by vortices within the kinetic pulverizer to produce a pulverized material; admixing the mining feedstock or the pulverized material with a chemical additive configured to selectively liberate the valuable component from the geological material; and subjecting the pulverized material to an extraction stage to produce a valuable component-rich stream and a valuable component-depleted stream.

Abstract: A process for treating a fines stream in a material recover facility (MRF), comprising: providing an MRF fines stream comprising breakable material and ductile material: subjecting the MRF fines streams to a one-pass kinetic pulverization stage to produce a pulverized material comprising a size-reduced fraction derived from the breakable material and an oversized fraction derived from the ductile material; withdrawing the pulverized material from the kinetic pulverizer; and subjecting the pulverized material to separation to produce a size-reduced stream and an oversized stream. Also provided is a system comprising a kinetic pulverizer, a pulverizer conveyor and a screen operatively coupled to the pulverizer conveyor to receive a pulverized stream and produce a sized-reduced stream and an oversized stream. The system can also include a magnetic separator and a dust collection system respectively located upstream and downstream of the kinetic pulverizer.

Abstract: The present disclosure relates to the treatment of streams derived from construction and/or demolition (C&D) debris, such as C&D fines streams, asphalt shingles, drywall, or wood. The process can include a kinetic pulverization stage through a kinetic pulverizer where the frangible materials are size-reduced and the ductile materials are liberated and remain as an oversized fraction. The feedstock can include infrangible materials that also remains as an oversized fraction. The pulverized material is then subjected to a separation stage, which may include mechanical and/or magnetic screening, to separate the oversized material comprising the ductile material, and optionally larger particles of the infrangible material, from the size-reduced material comprising the frangible material, and optionally small particles of infrangible material.

Abstract: The present disclosure relates to the treatment of streams derived from construction and/or demolition (C&D) debris, such as C&D fines streams, asphalt shingles, drywall, or wood. The process can include a kinetic pulverization stage through a kinetic pulverizer where the frangible materials are size-reduced and the ductile materials are liberated and remain as an oversized fraction. The feedstock can include infrangible materials that also remains as an oversized fraction. The pulverized material is then subjected to a separation stage, which may include mechanical and/or magnetic screening, to separate the oversized material comprising the ductile material, and optionally larger particles of the infrangible material, from the size-reduced material comprising the frangible material, and optionally small particles of infrangible material.

Abstract: The present disclosure relates to the treatment of streams derived from construction and/or demolition (C&D) debris, such as C&D fines streams, asphalt shingles, drywall, or wood. The process can include a kinetic pulverization stage through a kinetic pulverizer where the frangible materials are size-reduced and the ductile materials are liberated and remain as an oversized fraction. The feedstock can include infrangible materials that also remains as an oversized fraction. The pulverized material is then subjected to a separation stage, which may include mechanical and/or magnetic screening, to separate the oversized material comprising the ductile material, and optionally larger particles of the infrangible material, from the size-reduced material comprising the frangible material, and optionally small particles of infrangible material.

Abstract: A cellulite and fat reducing device and method utilizing optical emitters includes an array housing a plurality of optical emitters which are positioned to produce an optical output directed to a recipient, and a controller for instructing an operation of the array. The optical output being generated by a plurality of LED's cumulatively producing green light at approximately 529.6 nm, and at approximately 48,860 Lux, measurable at the array.

Abstract: A cellulite and fat reducing device and method utilizing optical emitters includes an array housing a plurality of optical emitters which are positioned to produce an optical output directed to a recipient, and a controller for instructing an operation of the array. The optical output being generated by a plurality of LED's cumulatively producing green light at approximately 529.6 nm, and at approximately 48,860 Lux, measurable at the array.

Abstract: A fat reducing device and method utilizing optical emitters includes an array housing a plurality of optical emitters which are positioned to produce an optical output directed to a recipient, and a controller for instructing an operation of the array. The optical output being generated by a plurality of LED's cumulatively producing red light at approximately 635 nm, and at approximately 40,000 Lux, measurable at the array. The method includes reducing the lipid content of subcutaneous adipocytes using the optical emitting device, by delivering red light at approximately 313.6 Lux at a wavelength of approximately 635 nm for between 1 and 8 minutes, resulting in a total delivery of 2.88 Joules to the subcutaneous adipocytes of the target area of the recipient.

Abstract: A fat reducing device and method utilizing optical emitters includes an array housing a plurality of optical emitters which are positioned to produce an optical output directed to a recipient, and a controller for instructing an operation of the array. The optical output being generated by a plurality of LED's cumulatively producing red light at approximately 635 nm, and at approximately 40,000 Lux, measurable at the array. The method includes reducing the lipid content of subcutaneous adipocytes using the optical emitting device, by delivering red light at approximately 313.6 Lux at a wavelength of approximately 635 nm for between 1 and 8 minutes, resulting in a total delivery of 2.88 Joules to the subcutaneous adipocytes of the target area of the recipient.

Abstract: A fat reducing device and method utilizing optical emitters includes an array housing a plurality of optical emitters which are positioned to produce an optical output directed to a recipient, and a controller for instructing an operation of the array. The optical output being generated by a plurality of LED's cumulatively producing red light at approximately 635 nm, and at approximately 40,000 Lux, measurable at the array. The method includes reducing the lipid content of subcutaneous adipocytes using the optical emitting device, by delivering red light at approximately 313.6 Lux at a wavelength of approximately 635 nm for between 1 and 8 minutes, resulting in a total delivery of 2.88 Joules to the subcutaneous adipocytes of the target area of the recipient.

Abstract: A cellulite and fat reducing device and method utilizing optical emitters includes an array housing a plurality of optical emitters which are positioned to produce an optical output directed to a recipient, and a controller for instructing an operation of the array. The optical output being generated by a plurality of LED's cumulatively producing green light at approximately 529.6 nm, and at approximately 48,860 Lux, measurable at the array.

Abstract: A system, apparatus, and method for managing recyclable materials are disclosed. In one embodiment, an apparatus is described, the apparatus comprising an inlet port for receiving the recyclable materials, a tube connected to the inlet port, an outlet port as part of the tube for expelling the recyclable materials, a screw blade mounted inside the tube and the inlet port along a tube longitudinal axis for moving the recyclable materials through the inlet port, the tube, and the outlet port, a motor coupled to the screw blade for rotating the screw blade, thereby moving the recyclable materials through the apparatus, and a receptacle installed onto the outlet port for receiving the recyclable materials.

Abstract: A system, apparatus, and method for managing recyclable materials are disclosed. In one embodiment, an apparatus is described, the apparatus comprising an inlet port for receiving the recyclable materials, a tube connected to the inlet port, an outlet port as part of the tube for expelling the recyclable materials, a screw blade mounted inside the tube and the inlet port along a tube longitudinal axis for moving the recyclable materials through the inlet port, the tube, and the outlet port, a motor coupled to the screw blade for rotating the screw blade, thereby moving the recyclable materials through the apparatus, and a receptacle installed onto the outlet port for receiving the recyclable materials.

Abstract: The present invention relates to compounds of Formula (I): wherein R3-R8, X, and Y are as described herein, processes for preparing the compounds, pharmaceutical compositions comprising the compounds, and use of the compounds and compositions in the prophylaxis or treatment of a GHSR receptor-related disorder. Examples of such disorders are obesity and related disorders such as diabetes type II, dyslipidemia and the metabolic syndrome Prader-Willi syndrome, cardiovascular diseases such as atherosclerotic vascular disease, angina pectoris, myocardial infarction and stroke, acromegaly and cancer, in particular breast, lung, prostate, thyroid and endocrine pituary carcinomas.

Abstract: Compounds of Formula (I): wherein R and R? are described herein, as are processes for preparing the compounds, pharmaceutical compositions comprising the compounds, and use of the compounds and compositions in the prophylaxis or treatment of a 5-HT2A receptor-related disorder.

Abstract: Compounds of Formula (I): wherein X, Y, Z, and R1 are as described herein, processes for preparing the compounds, pharmaceutical compositions comprising the compounds, and use of the compounds and compositions in the prophylaxis or treatment of a 5-HT2A receptor-related disorder.

Abstract: A radiation treatment apparatus (10) includes a diagnostic imaging scanner (12) that acquires a diagnostic image of a subject. A contouring processor (54) computes a radiation treatment objective based thereon. A radiation delivery apparatus (60) delivers radiation to the subject. An inverse planning processor (80) computes radiation beamlet parameters conforming with the radiation treatment objective by: grouping the beamlet parameters; assigning a weight to each group (82, 84, 86); optimizing a first group (82) to produce an intermediate dosage objective corresponding to the treatment objective weighted by a weight of the first group (82); and optimizing successive groups (84) to produce with the previously optimized groups (82) an increasing intermediate dosage objective corresponding to the treatment objective weighted by the combined weights of the previous and current groups (82, 84).

Abstract: A radiation treatment apparatus (10) includes a diagnostic imaging scanner (12) that acquires a diagnostic image of a subject. A contouring processor (54) computes a radiation treatment objective based thereon. A radiation delivery apparatus (60) delivers radiation to the subject. An inverse planning processor (80) computes radiation beamlet parameters conforming with the radiation treatment objective by: grouping the beamlet parameters; assigning a weight to each group (82, 84, 86); optimizing a first group (82) to produce an intermediate dosage objective corresponding to the treatment objective weighted by a weight of the first group (82); and optimizing successive groups (84) to produce with the previously optimized groups (82) an increasing intermediate dosage objective corresponding to the treatment objective weighted by the combined weights of the previous and current groups (82, 84).

Abstract: The data connector of the present invention securably receives at least two distinct types of mating connector plugs having different contact arrangements. The data connector includes a housing having a mating connector receiving cavity partially defined by a rear wall. The data connector further includes a printed circuit board (PCB) positioned within the housing cavity wherein the PCB has a plurality of signal contacts electrically coupled thereto and extending from a top surface thereof. The signal contacts, which are used to frictionally engage mating contacts in the plugs, are desirably arranged in at least two vertically spaced rows to accommodate the distinct plug configurations. Mounted behind a back surface of the PCB, the data connector includes cable termination devices for receiving and terminating individual conductors of a multiconductor cable. The conductors are electrically connected to the signal contacts via an electrical trace on the PCB.